We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+8.42%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$80B
AUM Growth
+$5.37B
Cap. Flow
-$213M
Cap. Flow %
-0.27%
Top 10 Hldgs %
23.95%
Holding
3,773
New
259
Increased
1,520
Reduced
1,671
Closed
192

Sector Composition

Rank Sector Weight
1 Technology 14.33%
2 Healthcare 8.9%
3 Financials 7.71%
4 Consumer Discretionary 6.92%
5 Industrials 6.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BDX icon
76
Becton Dickinson
BDX
$48.9B
$175M 0.22%
768,655
+40,767
+6% +$10M
BAC icon
77
Bank of America
BAC
$447B
$174M 0.22%
7,227,338
-181,740
-2% -$4.52M
LMT icon
78
Lockheed Martin
LMT
$139B
$173M 0.22%
451,074
-47,384
-10% -$18.1M
MDY icon
79
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27B
$173M 0.22%
509,770
-4,196
-0.8% -$1.43M
CVS icon
80
CVS Health
CVS
$122B
$170M 0.21%
2,913,250
-806,653
-22% -$50.2M
FTCS icon
81
First Trust Capital Strength ETF
FTCS
$7.99B
$170M 0.21%
2,683,294
+97,761
+4% +$6.11M
IWM icon
82
iShares Russell 2000 ETF
IWM
$81.5B
$170M 0.21%
1,132,321
+19,141
+2% +$2.88M
IBM icon
83
IBM
IBM
$223B
$168M 0.21%
1,448,074
+13,113
+0.9% +$1.54M
KMB icon
84
Kimberly-Clark
KMB
$35.9B
$168M 0.21%
1,134,594
-43,971
-4% -$6.6M
AMT icon
85
American Tower
AMT
$78.8B
$167M 0.21%
690,223
+9,006
+1% +$2.28M
GLD icon
86
SPDR Gold Trust
GLD
$143B
$165M 0.21%
929,439
+115,284
+14% +$20.7M
DHR icon
87
Danaher
DHR
$147B
$163M 0.2%
855,219
+14,937
+2% +$2.66M
BND icon
88
Vanguard Total Bond Market
BND
$161B
$161M 0.2%
1,829,148
-151,458
-8% -$13.4M
VUG icon
89
Vanguard Morningstar Growth ETF
VUG
$230B
$156M 0.2%
4,111,332
-148,434
-3% -$5.48M
TMO icon
90
Thermo Fisher Scientific
TMO
$222B
$153M 0.19%
346,512
+12,542
+4% +$5.18M
HON icon
91
Honeywell
HON
$77B
$152M 0.19%
981,231
+64,252
+7% +$9.55M
NKE icon
92
Nike
NKE
$62.5B
$152M 0.19%
1,211,084
+44,492
+4% +$4.78M
UL icon
93
Unilever
UL
$135B
$150M 0.19%
2,163,511
-87,451
-4% -$5.84M
VEU icon
94
Vanguard FTSE All-World ex-US ETF
VEU
$69.9B
$149M 0.19%
2,945,375
+405,326
+16% +$20.6M
ADP icon
95
Automatic Data Processing
ADP
$109B
$148M 0.19%
1,061,097
-28,171
-3% -$3.95M
CCI icon
96
Crown Castle
CCI
$31.3B
$146M 0.18%
875,021
+68,531
+8% +$11.3M
ACN icon
97
Accenture
ACN
$109B
$146M 0.18%
644,427
-380
-0.1% -$87K
TSLA icon
98
Tesla
TSLA
$1.31T
$145M 0.18%
1,017,288
-167,322
-14% -$19.8M
VEA icon
99
Vanguard FTSE Developed Markets ETF
VEA
$236B
$145M 0.18%
3,554,101
-56,053
-2% -$2.3M
GSLC icon
100
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
$16B
$144M 0.18%
2,120,681
-31,923
-1% -$2.14M

Similar funds

Raymond James & Associates's Q3 2020 Portfolio in Review

As of Q3 2020, Raymond James & Associates held 3,773 positions worth $80B, up 7.2% from $74.6B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates's Q3 2020 filing shows 259 new, 1,520 increased, 1,671 reduced and 192 closed positions. Its largest new stake was Rocket Companies: 405,835 shares worth $8.09M. The largest sale was Apple, an estimated $134M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q3 2020 buy was Rocket Companies: 405,835 shares worth $8.09M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q3 2020, an estimated $140M increase.
  • Raymond James & Associates's biggest Q3 2020 reduction was Apple, cutting an estimated $134M.
  • Raymond James & Associates fully exited Invesco Russell 1000 Dynamic Multifactor ETF in Q3 2020, selling an estimated $15.9M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $80B portfolio in Q3 2020.
  • Raymond James & Associates opened 259 new positions and closed 192 in Q3 2020.
  • Raymond James & Associates's portfolio value rose 7.2% quarter-over-quarter to $80B.

Based on Raymond James & Associates's 13F filing for Q3 2020, filed 4 Nov 2020.